Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia

Interventions: Drug: hLL1

First Posted Date: 2007-07-20

Last Posted Date: 2018-05-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 23

Registration Number: NCT00504972

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease

Completed

Conditions: Asthma
Lung Disease
Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date: 2007-07-20

Last Posted Date: 2015-04-21

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 75

Registration Number: NCT00504738

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Combined Agent Randomized Trial of Induction of Labor

Not Applicable

Completed

Conditions: Labor Induction
Cervical Ripening

First Posted Date: 2007-07-20

Last Posted Date: 2007-07-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 210

Registration Number: NCT00504465

Locations: 🇺🇸
New York Hospital Medical Center of Queens, Flushing, New York, United States
🇺🇸
The Brooklyn Hospital Center, Brooklyn, New York, United States
🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Efficacy Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma

Phase 1

Withdrawn

Conditions: Esophageal Neoplasms

Interventions: Genetic: AdcuCD40L
Genetic: Placebo

First Posted Date: 2007-07-20

Last Posted Date: 2016-05-04

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT00504322

Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)

Completed

Conditions: Interstitial Lung Disease
Asthma
COPD
Lung Cancer
Cystic Fibrosis

First Posted Date: 2007-07-20

Last Posted Date: 2016-05-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 600

Registration Number: NCT00504361

Locations: 🇶🇦
Hamad Medical Corporation, Doha, Qatar

Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes

Phase 4

Terminated

Conditions: Healthy

Interventions: Drug: Placebo
Drug: Propofol
Drug: Thiopental

First Posted Date: 2007-07-20

Last Posted Date: 2021-07-15

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 60

Registration Number: NCT00504894

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Feeding Tolerance in Preterm Infants

Conditions: Prematurity
Feeding Intolerance

First Posted Date: 2007-03-22

Last Posted Date: 2010-11-05

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 160

Registration Number: NCT00450697

Locations: 🇺🇸
New York Presbyterian Hospital; Weill Cornell Medical College; Department of Pediatrics; Division of Neonatology, New York, New York, United States

Platelet Activation Markers in Pediatric Cardiac Surgery

Completed

Conditions: Coronary Disease

First Posted Date: 2007-03-21

Last Posted Date: 2012-03-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 10

Registration Number: NCT00450151

Locations: 🇺🇸
NewYork-Presbyterian Hospital-Weill Cornell Medical College, New York City, New York, United States

Efficacy of Enteral Iron Supplementation in Critical Illness

Phase 2

Completed

Conditions: Anemic, Critically Ill Patients

Interventions: Drug: Ferrous Sulfate
Drug: Placebo Oral Tablet

First Posted Date: 2007-03-21

Last Posted Date: 2019-07-18

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT00450177

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section

Phase 2

Completed

Conditions: Cesarean Section
Nausea
Vomiting

Interventions: Drug: Saline Placebo

First Posted Date: 2007-02-09

Last Posted Date: 2017-05-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 53

Registration Number: NCT00432991

Locations: 🇺🇸
New York-Presbyterian Hospital; Weill Medical College of Cornell, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy